Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status (Q29619648)
Jump to navigation
Jump to search
scientific article (publication date: 20 May 2011)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status |
scientific article (publication date: 20 May 2011) |
Statements
Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status (English)
2 references
Eric Van Cutsem
Claus-Henning Köhne
István Láng
Marek P Nowacki
Igor Shchepotin
Joan Maurel
Sabine Tejpar
Michael Schlichting
Angela Zubel
Ilhan Celik
Philippe Rougier
2 references
29
2 references
15
2 references
Identifiers
3 references
3 references